Protective socks and gloves made from a three-layered fabric that is protected from microbial contamination by the same non-migrating antimicrobial found in DermaSilk.
Garments and tubular sleeves made from medical-grade, sericin-free fibroin silk, treated with a non-migrating antimicrobial agent.
Ultra-thin (0.3 mm), flexible, self-adhesive and transparent medical silicone sheet for the treatment and prevention of abnormal scars. Designed for continuous wear for up to 7 days. After removal, the skin should be cleansed and a new sheet applied if continued treatment is required.
A 1.2 mm thick, transparent, self-adhesive medical silicone sheet for the treatment and prevention of abnormal scars. Washable and reusable and can be worn under clothing or in combination with compression therapy. For optimal results, it should be worn for 12–23 hours per day.
Quick-drying, non-greasy and non-sticky medical silicone gel enriched with vitamin E. Forms an invisible matte finish, making it particularly suitable for use on the face or under cosmetic camouflage. Can be applied in a single smooth motion. Also available with SPF 40 UV protection for scars exposed to sunlight.
Concentrated medical hydrating gel-cream developed for the aftercare and hydration of vulnerable skin immediately after wound closure, combining freshly processed aloe barbadensis leaf juice (Aruba Aloe vera) with oils and ingredients such as jojoba oil, vitamin E and vitamin C to deeply hydrate, support restoration of the skin barrier, reduce itching and redness, help lower the risk of abnormal scar formation, and improve the flexibility of tight or less elastic skin, including skin affected by burns or scalds. Also available with added SPF 30 sun protection.
Clascoterone is an androgen receptor inhibitor. When applied topically to the skin, clascoterone acts locally, influencing multiple cellular and molecular acnegenic pathways with minimal systemic exposure.
Cream with 3.75% imiquimod, is an immune response modifier that is the lead compound of the imidazoline family.
Gel combination therapy of clindamycin and tretinoin. Clindamycin is a semisynthetic derivative of the parent compound lincomycin that is produced by Streptomyces lincolnensis and is predominantly bacteriostatic. Topical tretinoin has both comedolytic and anti-inflammatory effects. Tretinoin decreases cohesiveness of follicular epithelial cells resulting in decreased microcomedone formation. Additionally, tretinoin stimulates mitotic activity and increased turnover of follicular epithelial cells, causing extrusion of the comedones.